Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD Patients
To evaluate the rationality of different initial doses of enarodustat for the treatment of anemia in ND-CKD patients
Male or female patients aged 18-75 years (inclusive); [+5]
Patients with SF ≤100 μg/L and TSAT ≤20% at screening; [+22]